NKR-P1F is a member of the Natural Killer Cell Receptor (NKR) family, characterized by its significant role in the regulation of innate immune responses. This receptor, predominantly expressed on the surface of natural killer (NK) cells, functions as a critical mediator in the recognition and elimination of virally infected cells and tumor cells, contributing to the body's first line of defense against malignancy and infection. The NKR-P1F receptor is involved in the intricate balance of activating and inhibitory signals that govern NK cell activity, ensuring that these cells can respond rapidly to pathological challenges without inducing damage to healthy tissue. The specificity and function of NKR-P1F are delineated by its ability to bind ligands expressed on target cells, a process that is pivotal for the activation of NK cells and the subsequent initiation of cytotoxic responses.
The general mechanisms of NKR-P1F activation involve a complex interplay of signaling pathways that facilitate NK cell activation and function. Activation of NKR-P1F is typically initiated upon binding to its cognate ligands, leading to the transmission of intracellular signals that promote NK cell activation, cytokine production, and cytolytic activity. These signaling cascades involve the phosphorylation of tyrosine residues within the cytoplasmic domains of the receptor, engaging downstream signaling molecules and pathways that culminate in cellular activation. Additionally, the regulation of NKR-P1F-mediated activation is modulated by the interaction with co-stimulatory receptors and the cellular microenvironment, which can enhance or suppress the receptor's activity. This regulation ensures the precise control of NK cell-mediated responses, allowing for effective surveillance and elimination of pathogenic threats while maintaining cellular and tissue integrity. Understanding the mechanisms of NKR-P1F activation provides critical insights into the orchestration of innate immune responses and the molecular strategies employed by NK cells to counteract infection and tumorigenesis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) is a potent activator of Protein Kinase C (PKC) which is involved in the signaling pathway that leads to the activation of NKR-P1F. By activating PKC, PMA can contribute to the functional activation of NKR-P1F. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, an event known to be involved in the activation of NKR-P1F. The increased calcium concentration can enhance the functional activity of NKR-P1F. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, leading to increased cAMP levels. NKR-P1F is implicated in cAMP-dependent signaling pathways, thereby the increased cAMP levels can enhance NKR-P1F functional activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX inhibits phosphodiesterases, enzymes that degrade cAMP. By raising intracellular cAMP levels, IBMX can enhance NKR-P1F functional activity in cAMP-dependent signaling pathways. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
SB216763 is a potent and selective inhibitor of Glycogen Synthase Kinase 3 (GSK3). Inhibition of GSK3 can lead to the activation of downstream targets in the pathway, including NKR-P1F. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
BAPTA-AM is a cell-permeable calcium chelator. By modulating intracellular calcium levels, BAPTA-AM can influence the signaling events that lead to the functional activation of NKR-P1F. | ||||||
Calphostin C | 121263-19-2 | sc-3545 sc-3545A | 100 µg 1 mg | $343.00 $1642.00 | 20 | |
Calphostin C is a potent and specific inhibitor of Protein Kinase C (PKC). The inhibition of PKC can impact the downstream targets in the PKC pathway, leading to the functional activation of NKR-P1F. | ||||||
Ro 31-8220 | 138489-18-6 | sc-200619 sc-200619A | 1 mg 5 mg | $92.00 $245.00 | 17 | |
Ro-31-8220 is a potent PKC inhibitor. By inhibiting PKC, it can impact the downstream signaling events that lead to the functional activation of NKR-P1F. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082 is an inhibitor of IκB-α phosphorylation, which prevents NF-κB activation. This inhibition can indirectly lead to the functional activation of NKR-P1F in the NF-κB signaling pathway. | ||||||